[Abstract Only] Randomized Trial: Patients with COPD Exacerbation and Low Eosinophil Count May be Treated with Shorter Corticosteroid Treatment

24 May, 2019 | 05:19h | UTC

Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)

Commentary: 2 Minute Medicine Rewind May 20, 2019 (4th Summary)

See also: Video Summary – Medwire News (free audio)

 

Related Commentary on Twitter

 

Join our WhatsApp group

Free Updates in All Specialties!

Stay Updated in Your Specialty
No spam, just news
Unsubscribe with one click

 

Daily

 

Weekly or Less Often 
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •